Autoimmune Cytopenias as a Sign of Primary Immunodeficiency.

Status Active, not recruiting

Clinical Trial Summary

Autoimmune cytopenias resistant to treatment are among the most common clinical manifestations observed in patients with congenital alterations of the immune system, such as primary immunodeficiencies (PI). The exact contribution of immune system alterations to the pathogenesis of autoimmune cytopenias has not yet been fully elucidated. Moreover, conventionally employed therapeutic strategies often fail, leading to increased healthcare costs, high morbidity, and even mortality. Therefore, there is a need to establish clinical guidelines for diagnosis and to identify early biomarkers capable of identifying individuals responsive to therapy. Thus, a systematic approach to the study of such pathologies will allow for the identification of early biomarkers and facilitate the development of targeted therapeutic strategies

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Anemia
Cytopenia
Leukopenia
Primary Immunodeficiency Diseases
Thrombocytopenia

Clinical Trial Details

NCT number	NCT06276036
Study type	Interventional
Source	Meyer Children's Hospital IRCCS
Contact
Status	Active, not recruiting
Phase	N/A
Start date	July 23, 2019
Completion date	June 1, 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02104440` - Clinical Trial In The Treatment Of Allogeneic Post-Transplant Cytopenias With Sequential Infusion Of Allogeneic Mesenchymal Cells Expanded In Vitro	Phase 2
Active, not recruiting	`NCT03682029` - Epigenetics, Vitamin C, and Abnormal Blood Cell Formation - Vitamin C in Patients With Low-Risk Myeloid Malignancies	N/A
Recruiting	`NCT03026751` - Improving Diagnosis in Idiopathic Cytopenia Using Gene Sequencing	N/A
Recruiting	`NCT06430788` - A Study of Emapalumab for Pediatric Aplastic Anemia	Phase 2
Recruiting	`NCT04873102` - Danazol for Treatment of Cytopenias in Patients With Cirrhosis	Phase 2
Not yet recruiting	`NCT06285825` - A Pilot Study of Emapalumab for the Treatment of CAR T-Cell Therapy-Associated Prolonged Cytopenia	Early Phase 1
Terminated	`NCT03733249` - Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study	Phase 1/Phase 2
Recruiting	`NCT02958462` - Pre-myeloid Cancer and Bone Marrow Failure Clinic Study	N/A
Recruiting	`NCT05236764` - Haploidentical Hematopoietic Cell Transplantation Using TCR Alpha/Beta and CD19 Depletion	N/A
Recruiting	`NCT04741945` - Repurposing Metformin as a Leukemia-preventive Drug in CCUS and LR-MDS	Phase 2
Completed	`NCT01928537` - Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine	Phase 3
Recruiting	`NCT04419649` - A Study of KER-050 to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes	Phase 2
Completed	`NCT04070612` - National Prospective Cohort for Monitoring Children With Severe Autoimmune Cytopenia.
Active, not recruiting	`NCT03301168` - Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant	Phase 1/Phase 2
Terminated	`NCT02065869` - Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant	Phase 1/Phase 2
Completed	`NCT00367588` - Low Bacterial Diet in Patients With Cytopenia	N/A